Apollo Hospitals, one of the country’s largest private hospital chains, announced its September quarter performance today, post market hours, reporting a 26% year-on-year (YoY) rise in consolidated net profit to ₹477.2 crore, compared to ₹378.8 crore in the same quarter last year.
For Q2 FY26, the company reported a 12.8% YoY growth in revenue, reaching ₹6,304 crore.
At the operating level, EBITDA stood at ₹941 crore, marking a 15.46% YoY increase compared to ₹815 crore in Q2FY25, with margins expanding marginally by 30 basis points to 14.9%.
The company said that the Average Revenue per In-Patient (ARPOB) grew by 9% to Rs1,73,318 in Q2FY26.
Segment-wise performance
The Healthcare Services segment contributed the largest share at ₹3,217 crore, up from ₹2,974 crore in Q1FY26 and ₹2,920 crore in Q2FY25.
The company, in its earnings filing, said that Q2FY25 had a higher incidence of seasonal medical admissions, leading to a high base, whereas medical admissions were lower in Q2FY26. This low growth in medical admissions was partly offset by a 14% increase in revenue from CONGO specialties.
Meanwhile, the revenue from Retail Health and Diagnostics came in at ₹474 crore, compared to ₹435 crore in the preceding quarter and ₹404 crore a year ago.
Apollo HealthCo, which includes pharmacy distribution and digital health services, recorded revenue of ₹2,606 crore, higher than ₹2,472 crore in Q1FY26 and ₹2,282 crore in Q2FY25.
